Average Co-Inventor Count = 8.87
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Pharmaceutica Nv (19 from 2,076 patents)
2. Ortho-mcneil Pharmaceutical Corp. (1 from 363 patents)
3. 3-dimensional Pharmaceuticals, Inc. (1 from 76 patents)
21 patents:
1. 12134636 - Immunoglobulins and uses thereof
2. 11767354 - Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
3. 11732019 - Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
4. 11591379 - Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
5. 11401315 - Immunoglobulins and uses thereof
6. 10968265 - Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
7. 10968264 - Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
8. 10961293 - Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
9. 10858413 - Immunoglobulins and uses thereof
10. 10787495 - Immunoglobulins and uses thereof
11. 10640544 - Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
12. 10428134 - Immunoglobulins and uses thereof
13. 9193736 - PDE 10a inhibitors for the treatment of type II diabetes
14. 8796256 - Substituted thiazolidinedione indazoles, indoles and benzotriazoles as estrogen-related receptor-α modulators
15. 8344009 - Substituted phenoxy thiazolidinediones as estrogen related receptor-á modulators